Literature DB >> 17966494

Combination topical therapy in the treatment of acne.

James Q Del Rosso1.   

Abstract

Many medications are available for the management of acne. The armamentarium includes topical retinoids (ie, adapalene, tazarotene, tretinoin), antimicrobial and antibacterial agents (ie, benzoyl peroxide, clindamycin, erythromycin, sulfacetamide with or without sulfur), oral antibiotics (ie, doxycycline, minocycline, tetracycline), hormonal agents (ie, oral contraceptives, spironolactone), and systemic retinoids (ie, isotretinoin). Acne usually is treated with combination therapy to address its multifactorial pathophysiology. The combination of clindamycin 1%-benzoyl peroxide 5% gel, available as a stable formulation in a single tube, is efficacious and well-tolerated. The product's excipients, glycerin and dimethicone, minimize treatment-related irritation, thereby increasing patient compliance. Clindamycin-benzoyl peroxide may be well-tolerated when applied with topical retinoids, creating a more targeted and complete treatment strategy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17966494

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  4 in total

1.  Clindamycin Phosphate 1.2% and Benzoyl Peroxide 2.5% Gel for the Treatment of Moderate-to-severe Acne: An Update.

Authors:  Michael H Gold
Journal:  J Clin Aesthet Dermatol       Date:  2012-01

2.  Biochemical markers of oxidative and nitrosative stress in acne vulgaris: correlation with disease activity.

Authors:  Hani A Al-Shobaili; Abdullateef A Alzolibani; Ahmad A Al Robaee; Abdel-Raheim M A Meki; Zafar Rasheed
Journal:  J Clin Lab Anal       Date:  2013-01       Impact factor: 2.352

3.  Acne vulgaris treatment : the current scenario.

Authors:  Sanjay K Rathi
Journal:  Indian J Dermatol       Date:  2011-01       Impact factor: 1.494

4.  Clinical evidence on the efficacy and tolerability of a topical medical device containing benzoylperoxide 4%, retinol 0.5%, mandelic acid 1% and lactobionic acid 1% in the treatment of mild facial acne: an open label pilot study.

Authors:  Virginia Garofalo; Maria Vittoria Cannizzaro; Sara Mazzilli; Luca Bianchi; Elena Campione
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-05-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.